Intensive Course in Genomic Cancer Risk Assessment
The Intensive Course 2027 in Genomic Cancer Risk Assessment application is OPEN!
- The IC 2027 application will be open from April 1, 2026, to August 1, 2026.
- The IC 2027 session begins in October 2026 and concludes in February 2027.
Click APPLY HERE button below to submit your application!
The Intensive Course in Genomic Cancer Risk Assessment is a continuing medical education (CME) accredited certificate program for Physicians, Physician Assistants, Genetic Counselors, Master's or PhD in Genetics or Advanced Practice Nurses, and Geneticists.
The full course experience includes thirteen weeks of Distance Learning followed by four days of in-person Clinical Skills Workshops to translate the course experience into clinical practice.
Apply Early! Limited space available for full-course experience.
- Distance Learning with Clinical Skills Development Workshops
(Oct 26, 2026 - Feb 12, 2027 + Feb 22 - Feb 25, 2027)
A Distance Learning only track without the four-day in-person workshops is available for those who cannot join us for the full course experience.
- Distance Learning Only
(Oct 26, 2026 - Feb 12, 2027)
For questions about the course or application, please contact [email protected].
The in-person workshop experience is very immersive. I really enjoyed interacting with the staff, guest faculty, and participants. With the multidisciplinary course format, we all taught and learned from each other.
This was a great opportunity to learn from so many experts and people from in different settings, all contributing with one another. It was an amazing experience to be here and make new friends. This was one of the greatest learning experiences I've had.
The workshops were outstanding. They encouraged dynamic brainstorming, close collaboration, and benefited from the expertise of mentors. The final day of the workshop was especially valuable.
Learning Outcomes
- Integrate evidence-based cancer genetics and genomics knowledge into clinical practice
- Apply skills commensurate with practitioner-level proficiency into the cancer risk assessment, risk management, and targeted therapeutics
- Recommend risk-appropriate options for cancer surveillance and prevention as part of the cancer risk assessment, including imaging, chemopreventive, and surgical interventions
- Incorporate understanding of medical, ethical, legal, and psychosocial ramifications of cancer risk counseling and testing into clinical practice and research collaboration
- Examine the roles of hereditary cancer registries, cancer prevention studies, and genomically-informed clinical trials in patient care
- Realize greater professional self-efficacy related to genetic cancer risk assessment skills
- Incorporate web-based resources into ongoing practice-based education, professional development, and research support
- Discuss possible barriers and biases which may impact patient care (i.e., race, ethnicity, language, gender identity/orientation, age, socioeconomic status, attitudes, feelings, or other characteristics)